FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223945879> ?p ?o ?g. }

• W4223945879 endingPage "342" @default.
• W4223945879 startingPage "332" @default.
• W4223945879 abstract "The purpose of this study was to evaluate the effects of Cetobacterium somerae XMX-1 fermentation product on gut and liver health and resistance against bacterial infection in genetically improved farmed tilapia (GIFT, Oreochromis niloticus). Fingerling GIFTs (n = 120; initial weight 1.33 ± 0.00 g) were randomly assigned to twelve 90-L tanks (four tanks per diet, 10 fish per tank) with three groups: control group (basal high fat diet), 1% XMX-1 group and 2% XMX-1 group (basal diet supplemented with 10 and 20 g XMX-1/kg feed respectively). After 49 days feeding trial, the growth performance and gut and liver health parameters of tilapia were evaluated. Also the gut microbiota and virome were detected by sequencing. 2% XMX-1 fermentation product had no effect on growth performance. For gut health, the expression of hypoxia-inducible factor-lα (Hif-1α) tend to increase in 1% XMX-1 group (P = 0.053). The expression of intestinal interleukin-6 (IL-6) and tumor growth factor β (TGF-β) was significantly down-regulated in 1% and 2% XMX-1 groups (P < 0.05), and the intestinal expression of interleukin-1β (IL-1β) had a trend to decrease (P = 0.08) in 1% XMX-1 group versus control. 1% and 2% XMX-1 groups also increased the intestinal expression of tight junction genes Claudin (P = 0.06 and 0.07, respectively). For liver health, XMX-1 fermentation product significantly decreased liver TAG (P < 0.05). Furthermore, the hepatic expression of lipid synthesis gene fatty acid synthase (FAS) was significantly decreased and the expression of lipid catabolism related-gene uncoupling protein 2 (UCP2) was significantly increased in 1% XMX-1 and 2% XMX-1 groups (P < 0.01). And the hepatic expression of IL-1β and IL-6 significantly decreased in 1% XMX-1 and 2% XMX-1 groups (P < 0.05). XMX-1 fermentation product increased the abundance of Fusobacteria in the gut microbiota and 2% XMX-1 group led to alteration in the virome composition at family level. Lastly, the time of tilapia death post Aeromoans challenge was delayed in 1% XMX-1 and 2% XMX-1 groups compared with control. To sum up, our results show that the dietary supplementation of XMX-1 fermentation product can improve the gut and liver health as well as the resistance against pathogenic bacteria of tilapia." @default.
• W4223945879 created "2022-04-19" @default.
• W4223945879 creator A5005048329 @default.
• W4223945879 creator A5016131030 @default.
• W4223945879 creator A5017183277 @default.
• W4223945879 creator A5021384155 @default.
• W4223945879 creator A5046415901 @default.
• W4223945879 creator A5064163486 @default.
• W4223945879 creator A5066766215 @default.
• W4223945879 date "2022-05-01" @default.
• W4223945879 modified "2023-10-18" @default.
• W4223945879 title "Effect of dietary supplementation of Cetobacterium somerae XMX-1 fermentation product on gut and liver health and resistance against bacterial infection of the genetically improved farmed tilapia (GIFT, Oreochromis niloticus)" @default.
• W4223945879 cites W1827287116 @default.
• W4223945879 cites W1912394394 @default.
• W4223945879 cites W1966237384 @default.
• W4223945879 cites W1985879362 @default.
• W4223945879 cites W1987150557 @default.
• W4223945879 cites W1993799118 @default.
• W4223945879 cites W2001913850 @default.
• W4223945879 cites W2002971672 @default.
• W4223945879 cites W2006202375 @default.
• W4223945879 cites W2006326944 @default.
• W4223945879 cites W2008733625 @default.
• W4223945879 cites W2015035889 @default.
• W4223945879 cites W2021027516 @default.
• W4223945879 cites W2023097321 @default.
• W4223945879 cites W2025154140 @default.
• W4223945879 cites W2034284589 @default.
• W4223945879 cites W2038762405 @default.
• W4223945879 cites W2051591207 @default.
• W4223945879 cites W2054094842 @default.
• W4223945879 cites W2055422882 @default.
• W4223945879 cites W2058025271 @default.
• W4223945879 cites W2060677553 @default.
• W4223945879 cites W2062421917 @default.
• W4223945879 cites W2074390592 @default.
• W4223945879 cites W2076305714 @default.
• W4223945879 cites W2077581368 @default.
• W4223945879 cites W2077663246 @default.
• W4223945879 cites W2081319466 @default.
• W4223945879 cites W2085812736 @default.
• W4223945879 cites W2088653832 @default.
• W4223945879 cites W2113290646 @default.
• W4223945879 cites W2115342886 @default.
• W4223945879 cites W2124937554 @default.
• W4223945879 cites W2140848380 @default.
• W4223945879 cites W2145189896 @default.
• W4223945879 cites W2154774779 @default.
• W4223945879 cites W2297226684 @default.
• W4223945879 cites W2333541373 @default.
• W4223945879 cites W2406211271 @default.
• W4223945879 cites W2466475499 @default.
• W4223945879 cites W2490132574 @default.
• W4223945879 cites W2558149015 @default.
• W4223945879 cites W2598284133 @default.
• W4223945879 cites W2604544288 @default.
• W4223945879 cites W2624914616 @default.
• W4223945879 cites W2647718487 @default.
• W4223945879 cites W2735712510 @default.
• W4223945879 cites W2736401245 @default.
• W4223945879 cites W2757383628 @default.
• W4223945879 cites W2761279879 @default.
• W4223945879 cites W2782082358 @default.
• W4223945879 cites W2800222992 @default.
• W4223945879 cites W2809867328 @default.
• W4223945879 cites W2888867525 @default.
• W4223945879 cites W2896855628 @default.
• W4223945879 cites W2901164417 @default.
• W4223945879 cites W2913453177 @default.
• W4223945879 cites W2963549195 @default.
• W4223945879 cites W2981895296 @default.
• W4223945879 cites W3000013430 @default.
• W4223945879 cites W3011930523 @default.
• W4223945879 cites W3022598853 @default.
• W4223945879 cites W3041011677 @default.
• W4223945879 cites W3165734954 @default.
• W4223945879 cites W3166734588 @default.
• W4223945879 cites W318521052 @default.
• W4223945879 cites W3213552759 @default.
• W4223945879 doi "https://doi.org/10.1016/j.fsi.2022.04.019" @default.
• W4223945879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35430347" @default.
• W4223945879 hasPublicationYear "2022" @default.
• W4223945879 type Work @default.
• W4223945879 citedByCount "19" @default.
• W4223945879 countsByYear W42239458792022 @default.
• W4223945879 countsByYear W42239458792023 @default.
• W4223945879 crossrefType "journal-article" @default.
• W4223945879 hasAuthorship W4223945879A5005048329 @default.
• W4223945879 hasAuthorship W4223945879A5016131030 @default.
• W4223945879 hasAuthorship W4223945879A5017183277 @default.
• W4223945879 hasAuthorship W4223945879A5021384155 @default.
• W4223945879 hasAuthorship W4223945879A5046415901 @default.
• W4223945879 hasAuthorship W4223945879A5064163486 @default.
• W4223945879 hasAuthorship W4223945879A5066766215 @default.
• W4223945879 hasConcept C100544194 @default.
• W4223945879 hasConcept C2778658382 @default.
• W4223945879 hasConcept C2779286987 @default.
• W4223945879 hasConcept C2909208804 @default.

• next